President Trump's 2026 budget proposes cutting NIH grants to universities, academic medical centers, and other institutions ...

Trump health officials signal eased FDA rules for rare disease gene therapy, but concerns linger over safety, oversight, and ...

Omada Health, a 14-year-old digital health company supporting chronic disease patients, has yet to generate profits.

RFK Jr.'s admission raises new concerns about a possible upcoming wave of reckless stem cell deregulation from this ...

A large government study published Thursday shows more definitively than ever before that Americans’ self-reported race is a ...

The NIH archives of the Human Genome Project could fall victim to Trump administration cuts, writes a former archivist.

It looks like the NIH is thinking about AI differently than the FDA, who earlier this week released a “rushed” AI tool across ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

From STAT’s Adam Feuerstein: Another example of why biotech is a tough business.

From 2020 to 2024, universities contributed patents underpinning 50% of FDA-approved drugs. 87% of those academic ...

Novo Nordisk’s stock has tumbled over 50% since its peak around a year ago, and it just ousted its CEO. Former employees say ...

HHS Secretary Robert F. Kennedy Jr. said that the FDA would look for ways to fast-track approval for rare disease treatments ...